Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/12/2014 - 04/29/2017

This course is closed. Please look for other available products in CPNP University.

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Migraine ranks as one of the world’s most prevalent illnesses, causing significant amounts of debilitation, pain, and lost productivity. Yet patients and clinicians tend to underestimate migraine’s pervasiveness and impact. Treatment of migraine remains less than optimal. In select suffers episodic migraine can evolve to a chronic state, where the patients endures a headache on the majority of the days of the month. Overuse of medications, particularly narcotics and butalbital, have been implicated as a chief cause for the development of chronic migraine.  

This program will review migraine’s epidemiology, discuss evidence-based treatment recommendations, highlight the risks of narcotic and butalbital medications, and feature opportunities for pharmacists to improve care. The session will conclude by reviewing onabotulinumtoxinA, the only FDA-approved treatment for chronic migraine.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Discuss migraine headache prevalence and burden.
  2. Identify and summarize current prevention strategies for people with chronic migraine headaches.
  3. Discuss current efficacy and safety of using botulinum toxin and evaluate place in therapy.
  4. Develop treatment plan for botulinum toxin use in a patient with refractory migraines.

Continuing Education Credit and Disclosures

Activity Dates: 06/12/2014 - 04/29/2017
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-14-020-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hours (0.10 CEUs) of knowledge-based continuing education credit. The ACPE universal program number assigned to this course is 0284-0000-14-020-H01-P (1.0 contact hours).